Pfizer Inc.
Product Announcements
Save
April 29, 2024 3:40 PM
-
no-reply@q4inc.com
Pfizer Inc. - FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
FDA grants full approval for TIVDAK to treat recurrent or metastatic cervical cancer.
Pfizer Inc. has added a new press release to its website: FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer Click here for a complete listing of Pfizer Inc. press releases. To unsubscribe from this list, please v
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Save to Board
This is some text inside of a div block.
This is some text inside of a div block.
1 selected
DoneYou have reached your plans limit
To create or access more boards you need to upgrade.
Saved to “Lululemon” board
1 item added
Dismiss